Actively Recruiting
Cardiac Autonomic Dysfunction As a Sign of Irreversible Advanced Heart Failure
Led by University Hospital Bispebjerg and Frederiksberg · Updated on 2025-02-25
200
Participants Needed
1
Research Sites
73 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main hypothesis is that autonomic dysfunction cannot improve among patients reaching end-stage heart failure. To evaluate this, patients admitted with acute decompensated heart failure in Bispebjerg hospital, and history one or more admissions with the same condition within the prior year, will undergo repeated brief heart monitoring (10 min). Baseline recordings (at admission) will be compared with equivalent measurements before discharge to explore whether heart rate variability increases. Patients will be followed for six months after discharge from the hospital.
CONDITIONS
Official Title
Cardiac Autonomic Dysfunction As a Sign of Irreversible Advanced Heart Failure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18-years age or older
- admitted with acute decompensated heart failure for less than 48 h
You will not qualify if you...
- pacemaker
- not signed informed consent
- other heart rhythm than sinus rhythm or atrial fibrillation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cardiology department Y, Bispebjerg-Frederiksberg Hospital
Frederiksberg, Denmark, 2000
Actively Recruiting
Research Team
H
Helena Dominguez
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here